Pfizer has terminated a Phase I trial of its investigational STING therapy in advanced solid tumors, according to an update ...
Facing declining valuations and funding challenges, public biotechs like bluebird bio are going private to restructure, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback